# MIMS Accelerates Product Innovation and International Growth

- Link: https://www.thailand-business-news.com/pr-news/mims-accelerates-product-innovation-and-international-growth
- Published: 2026-09-28T09:00:00+07:00
- Author: Media OutReach

#### _Launch of new products, market expansion and AI-enabled capabilities mark the next stage of growth for a global healthcare technology company anchored by six decades of trusted medical data and expertise._

SINGAPORE – [Media OutReach Newswire](https://www.media-outreach.com/) – 28 September
2026 – MIMS Group, an Asia-Pacific provider of medicines information, clinical decision
support, medical communications and marketing services, is accelerating product 
innovation and international growth as it transforms its long-standing healthcare
data, content and market expertise into new technology platforms, customer applications
and services.

 Following the appointment of **Sohil Goswami as Group CEO in January 2026**, MIMS
has reshaped its businesses and leadership structure to support its next phase of
growth.

 The company is now ready to harness its data, technology and healthcare relationships
to create scalable products and new business models across markets.

 **Clinical Decision Support expands across products and markets**

 MIMS recently launched **MIMS Pulse**, its next-generation Clinical Decision Support
platform that combines MIMS’ medicines data and clinical knowledge with modern technology,
flexible deployment and integration capabilities to support safer and more efficient
clinical workflows.

 Alongside MIMS Pulse, the company is scaling **eMIMS Plus**, a platform that brings
MIMS’ trusted medicines information into a modern digital experience designed to
achieve quality use of medicine. Conceived and first launched in Australia under
Goswami’s guidance in his previous role leading the CDS Business, eMIMS Plus is 
now available in India and Malaysia with plans to expand across Southeast Asia, 
introduce new clinical modules, as well as extend into new healthcare categories
through **Drugs4Dent**.

 MIMS is developing its **global CDS offering**, building on MIMS Pulse and eMIMS
Plus to take its clinical data and technology capabilities into new markets and 
customer environments.

 **Medical Marketing business transforms for global growth**

 MIMS’ Medical Communications business is expanding internationally, with commercial
capabilities in the **US and UK** creating opportunities with new client segments
and global life sciences organisations. The business continues to develop digital
events, AI-enabled content capabilities and new customer engagement models.

 MIMS is exploring **more connected, intelligence-led services** – helping healthcare
and life sciences organisations better understand their markets, engage healthcare
professionals and make more informed decisions.

 This work represents an important step beyond MIMS’ traditional information and
communications models, applying its content data and market reach to new technology-
enabled services.

 Goswami said:

 “For decades, healthcare professionals have trusted MIMS’ medicines information
and expertise. Today, we are transforming that foundation into the next generation
of digital products, platforms and services.

 We have been reshaping the business – bringing our capabilities together, strengthening
our technology and building new ways to serve customers across markets.

 Our opportunity is to turn trusted medical data, deep healthcare relationships 
and market knowledge into the next generation of products, platforms and services
to build a MIMS that can compete and grow globally while staying relevant to the
markets we serve.”

 The developments form part of a broader evolution across MIMS as the company builds
on its established strengths while extending its products, capabilities and reach
into new areas of healthcare.

Hashtag: #MIMS #MIMSPulse #eMIMSPlus #clinicaldecisionsupport #medicalmarketing #
AIinhealth #digitalhealth #healthcareinnovation #healthtech #HCP

The issuer is solely responsible for the content of this announcement.

#### About MIMS: Empowering Healthcare Communities to Improve Patient Outcomes

MIMS is Asia’s largest multi-channel provider of drug information, medical communications,
events management, marketing, and recruitment services. Established in 1963, our
work empowers healthcare professionals to improve patient outcomes by facilitating
knowledge exchange and better decision-making. Today, MIMS is present in 17 markets
globally with over two million healthcare professional subscribers to our drug &
resource portal, digital and print publications.

 Combining healthcare communications expertise with our established networks and
presence in the Asian healthcare community, we enable clients to engage their stakeholders
in meaningful dialogue through a range of medical and marketing communications services.

 We facilitate long-term placement of nurses, pharmacists and doctors across the
globe to match the demands of healthcare institutions looking for high-calibre practitioners.

 MIMS has offices in the following global markets: 
 Singapore (headquarters), Australia,
China, Germany, Hong Kong SAR, Indonesia, India, Ireland, Japan, Korea, Malaysia,
New Zealand, Philippines, Taiwan, Thailand, UAE, Vietnam

 Learn more at [https://corporate.mims.com/](https://corporate.mims.com/) or follow
[https://www.linkedin.com/company/mims-pte-ltd/](https://www.linkedin.com/company/mims-pte-ltd/)

![](//track.media-outreach.com/index.php/WebView/489540/36955)

**Source** : [MIMS Accelerates Product Innovation and International Growth](https://www.media-outreach.com/news/singapore/2026/09/28/489540/?rand=186006)

---

  |  This article was produced by Media OutReach, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not reflect the opinions of Thailand Business News. |

---

![Media OutReach Newswire](https://i0.wp.com/www.thailand-business-news.com/wp-content/
uploads/2025/04/media-outreach-20025.png?ssl=1)
